A gene can be associated with disease without revealing how it acts. This study builds a bridge from genetic signals to cellular experiments — while showing why cell identity matters.

THE SHORT READ
  • The team used 261 stem-cell lines from 254 European donors to make microglia-like cells.
  • A separate cellular-phenotype analysis included 243 donors; the roughly two million retained cells are not two million donors.
  • A TREM2 perturbation had different effects in two laboratory cell types. This is not evidence for an individual diagnosis or treatment.
THE STUDY AT A GLANCEMicroglia genetics · Perez-Alcantara et al.
Paper date
17 November 2026
Starting resource
261 lines from 254 donors
Laboratory model
Microglia-like cells

Original publication: 17 Nov 2026 · The date above refers to this brief.

THE NUMBERS, IN CONTEXT

A count within a count

genes

Colocalizing genes79
Of those, low prior prioritization score37
080
The 37 are part of the 79, not a separate group to add. The authors used a locus-to-gene score below 0.2; this is not a patient risk score.
THE EXPERIMENT, EXPLAINED

Three steps from genetics to a test

  1. Profile

    Measure gene activity and cell behavior in stem-cell-derived models.

  2. Compare

    Test genetic signals for overlap with disease-association datasets.

  3. Perturb

    Investigate selected genes in cell models and compare contexts.

Original reading diagram, not a publisher figure, experimental protocol or treatment recommendation.

Why use cells made in a dish?

Microglia are immune cells of the central nervous system, but obtaining living human brain microglia for large experiments is difficult. The researchers turned induced pluripotent stem cells into microglia-like cells and studied them in groups, or pools. These cells model aspects of microglia; they are not a complete human brain.

Source 1 ↗

Lines, donors and cells are different counts

The paper describes 261 stem-cell lines from 254 donors of European ancestry. Some donors contributed more than one line. After quality control the pooled experiment retained approximately two million cells. An analysis of migration and particle uptake used 243 donors; these numbers answer different questions and should not be added.

Source 1 ↗

From an association to a more specific question

The authors compared genetic variation with gene activity, then examined overlap with previously published disease-association studies. They reported 79 unique genes for which signals colocalized. Colocalization is a statistical argument about shared signals, not proof that changing a particular gene will prevent disease. The paper notes that the samples have limited ancestry diversity.

Source 1 ↗

One surprising laboratory comparison

The team also perturbed TREM2 in cell models and measured a signal related to engulfment. In one matched-line comparison, the signal rose in microglia-like cells and fell in macrophage-like cells. The assay measures several linked processes, including uptake and degradation; an opposite direction in a dish does not establish what will happen in a person’s brain.

Source 1 ↗

What would strengthen the bridge?

Independent work in larger, more diverse donor collections, different cellular states and other models could test which relationships persist. An author reports founding and consulting for a biotechnology company, while two were company employees when the manuscript was submitted. The earlier Press-News genetic-atlas story explains why shared genetic signals still require careful interpretation.

Source 1 ↗
TRACE THE EVIDENCE

A cell, a line and a donor are not the same unit

Publisher HTML: abstract, selected Results, Methods, Figure 3 and 5 captions, and competing interests, accessed through a research-search interface. Publisher metadata and abstract also checked. Supplements, source-data files, code and clinical records were not independently audited. No publisher figure reproduced.

01Did the study use 261 different people?

What was observed
The Methods describe 261 iPSC lines from 254 European donors.
Where the conclusion stops
Some donors contributed more than one line.

Source 1 · Publisher Methods, human iPSC maintenance

02Does TREM2 perturbation always move the assay in the same direction?

What was observed
A matched-line comparison reported increased signal in microglia-like cells and reduced signal in macrophage-like cells.
Where the conclusion stops
The direction is specific to the tested assay and cell context.

Source 1 · Publisher Results, divergent phagocytic activity and Figure 5k

Numbers you can inspect

MeasureValue & unitOrigin & method
Stem-cell lines261 linesReported Human iPSC lines in the starting resource.
Source 1 · Publisher Methods, human iPSC maintenance
Donors in the starting resource254 donorsReported European donors contributing the 261 lines.
Source 1 · Publisher Methods, human iPSC maintenance
Donors in phenotype analysis243 donorsReported Donors in the uptake and migration analysis.
Source 1 · Publisher Figure 3a caption
Unique colocalizing genes79 genesReported Unique genes whose gene-activity associations colocalized with disease GWAS signals.
Source 1 · Publisher Results, genetic overlap
Genes with low prioritization score37 genesReported Subset of the 79 with reported locus-to-gene score below 0.2.
Source 1 · Publisher Results, genetic overlap
Low-score proportion46.8 percentCalculated 37 divided by 79 times 100, rounded to one decimal place.
Source 1 · Publisher Results, genetic overlap

Compare the actual experiments

These studies answer different questions. Read the unit and endpoint before comparing results.

StudyUnit & settingReadoutInterpretation boundary
Genetic colocalization

Source 1 · Publisher Results, genetic overlap

Genes and genetic lociOverlap between molecular and disease-association signalsA statistical shared-signal hypothesis, not a proven therapy.
TREM2 cell comparison

Source 1 · Publisher Results and Figure 5k

Microglia-like and macrophage-like cellsUptake-associated readout after perturbationThe assay and model differ from a human clinical outcome.
Download evidence table (CSV)

The export includes claims, available numbers, methods and source locations. It contains our reading notes and published summaries; it is not raw participant data or an independent reanalysis.

Evidence update · 17 Nov 2026
First publication. Reported observations, arithmetic and proposed follow-up questions are separated. No raw-data reanalysis. AI source check; no human editorial or clinical review.

CONNECT THE EVIDENCE

A map, a genetic overlap and an experiment

Reading questionWhat the paper reportsWhat remains open
Cell resource261 lines from 254 donors; about two million cells after quality controlLines and cells are not independent patients
Phenotype analysis243 donors in the uptake and migration analysisA distinct analysis, not an additional cohort to add
Genetic overlap79 unique colocalizing genes across four disease studiesA shared signal does not prove treatment benefit
TREM2 comparisonOpposite assay directions in two cell typesThe model is not an outcome in a patient

Original Press-News reading framework. Follow-up questions are our interpretation, not experiments performed by the authors.

READER QUESTIONS

Your questions, answered

Were two million people studied?

No. Approximately two million cells were retained after quality control. The resource comprised 261 lines from 254 donors.

Does a genetic overlap prove that a gene causes disease?

No. It can support a shared-signal hypothesis, which requires further testing.

Were these cells taken directly from living brains?

The main model used microglia-like cells generated from human induced pluripotent stem cells.

Does the TREM2 result show how to treat dementia?

No. It compares laboratory cell responses and does not establish a treatment effect in people.

LIMITATIONS

Limits of this interpretation

  • The donors were of European ancestry, so findings need evaluation in more diverse populations.
  • Stem-cell-derived microglia-like cells are a model and do not reproduce the complete human brain.
  • Colocalization and cell assays do not establish individual disease risk or treatment effects.
  • A reported engulfment readout combines uptake, acidification and degradation; results can depend on cell type and state.
  • The paper discloses biotechnology and pharmaceutical affiliations.
SOURCE NOTES

Sources & transparency

  1. Perez-Alcantara, Washer, Chen et al. (2026): Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk

    Publisher HTML: abstract, selected Results, Methods, Figure 3 and 5 captions, and competing interests, accessed through a research-search interface. Publisher metadata and abstract also checked. Supplements, source-data files, code and clinical records were not independently audited. No publisher figure reproduced. · Accessed 17 Nov 2026

    DOI: 10.1038/s41588-026-02843-0

Prepared and source-checked with AI. Press-news Team is the collective publication byline, not a medical reviewer. No human editorial or clinical review has taken place. This educational article examines research methods and laboratory or observational findings, not individual diagnosis or treatment. We did not conduct these experiments or reanalyse raw data. Reported results, our interpretation and proposed future tests are separated. Source-access limits are recorded below. Photographs are illustrative.

Source check: AI source check — selected primary results, captions and study boundaries

Clinical review: Not applicable to this educational guide

Suggest a correction